Latest stories on SION
Sionna Therapeutics price target raised to $6 from $5 at Wedbush
The Fly61 · neutralanalyst
Stifel maintains Hold on Sionna Therapeutics stock at $7 target
Investing.com Analyst Ratings50 · neutralanalyst
Sionna Therapeutics, Inc. (SION) Discusses Post-Hoc Analysis of PreciSION CF Trial and Advancement of Dual Combination Program Transcript
Seeking Alpha63 · neutralproduct/pr
Citizens reiterates Market Perform on Sionna Therapeutics stock
Investing.com Analyst Ratings50 · neutralanalyst
Why is Sionna Therapeutics stock sliding today?
Investing.com Markets34 · bearishgeneral
Sionna stock falls after staff cuts, pivot to new CF drug
Investing.com Markets34 · bearishgeneral
Sionna Therapeutics to reduce workforce by 46%
The Fly28 · bearishgeneral
Sionna Therapeutics to advance SION-451 + SION-2222 into AscenSION CF POC trial
The Fly63 · neutralproduct/pr
Sionna Therapeutics, Inc. (SION) files 8-K
SEC 8-K50 · neutralgeneral
Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial
GlobeNewswire67 · bullishproduct/pr
Robbins LLP Reminds Investors it is Investigating Sionna Therapeutics for Potential Securities Violations
GlobeNewswire34 · bearishgeneral
Sionna Therapeutics (SION) Securities Investigation Notice - Levi & Korsinsky
PR Newswire22 · bearishgeneral
SION Investors Have Opportunity to Join Sionna Therapeutics, Inc. Fraud Investigation with SBS Law
Barchart50 · neutralgeneral
Sionna Therapeutics Faces Scrutiny After Phase 2a Trial Miss—Shareholder Investigation Launched
August 12, 2026
MarketChameleon28 · bearishgeneral
Sionna's SION-719 Failure Changes Everything (Rating Downgrade)
Seeking Alpha28 · bearishproduct/pr
One Company’s Clinical Miss Is Another’s Moat: Vertex Rallies as Sionna’s CF Bet Collapses
Yahoo Top32 · bearishproduct/pr
Sionna Therapeutics Rises 15 9
The Fly58 · neutralgeneral